References
- Böcker W, Denk H, Heitz PU. Pathologie. Urban & Fischer Verlag; 2003.
- Stojadinovic S, Reinert S, Philippou S. [Problems in diagnosis and therapy of carcinoma in stroma-abundant pleomorphic adenoma of the parotid gland]. Mund Kiefer Gesichtschir. 1998; 2(5)266–9
- Rice DH. Salivary gland disorders. Neoplastic and nonneoplastic. Med Clin North Am 1999;83(1):197–218, xi.
- Seifert G. [Carcinoma in pre-existing Warthin tumors (cystadenolymphoma) of the parotid gland. Classification, pathogenesis and differential diagnosis]. Pathologe 1997; 18(5)359–67
- Spiro RH. The management of salivary neoplasms: An overview. Auris Nasus Larynx 1985; 12(Suppl 2)S122–S127
- Riede UN, Werner M, Schäfer HE. Allgemeine und spezielle Pathologie. 41st ed. Deutsches Ärzteblatt; 2004.
- Major salivary glands (parotid, submandibular, and sublingual). American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002. p 53–58.
- Altemani A, Martins MT, Freitas L, Soares F, Araujo NS, Araujo VC. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 2005; 46(6)635–41
- Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Int J Radiat Oncol Biol Phys 2007; 67(1)138–43
- Nouraei SA, Hope KL, Kelly CG, McLean NR, Soames JV. Carcinoma ex benign pleomorphic adenoma of the parotid gland. Plast Reconstr Surg 2005; 116(5)1206–13
- Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 2001; 23(9)705–12
- Batsakis JG. Recurrent mixed tumor. Ann Otol Rhinol Laryngol 1986; 95(5 Pt 1)543–4
- Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 2001; 32(6)596–604